Download presentation
Presentation is loading. Please wait.
Published byFlora Wright Modified over 7 years ago
1
New Use for LDN: Sarcoidosis Leonard Weinstock, MD Associate Professor of Clinical Medicine Washington University School of Medicine President, Specialists in Gastroenterology
2
Experiences with LDN “Conditions where LDN could be of benefit” “Conditions where LDN could be of benefit” 176 diseases, syndromes, and disorders 176 diseases, syndromes, and disorders Limited number of publications Limited number of publications www.ldnresearchtrust.org
3
My LDN Experience: (N>1200) Alopecia areata Alopecia areata Chronic fatigue synd. Chronic fatigue synd. Complex regional pain * Complex regional pain * Constipation * Constipation * Crohn’s disease * Crohn’s disease * Dercum’s disease Dercum’s disease Eczema Eczema Fibromyalgia * Fibromyalgia * AIDS * AIDS * Interstitial cystitis Irritable bowel syndrome * Multiple sclerosis * Prostatitis (Type III) Restless legs syndrome Sarcoidosis Small intestinal bacterial overgrowth Ulcerative colitis *
4
Sarcoidosis Granulomatous disorder with T-cells Granulomatous disorder with T-cells & macrophages in multiple organs & macrophages in multiple organs CD3+ cells, CD4+ cells w/ HLA-DR antigen, & high CD4/CD8 ratio in bronchus CD4+ CD29+ memory T-cells increased Iida K et al. Thorax 1997;52:431-7.
5
Sarcoidosis Special T-cell interactions in pulmonary and liver sarcoidosis Activated memory T-cells with CD11a Iida K et al. Thorax 1997;52:431-7.
6
Sarcoidosis: Pathogenesis Genetic susceptibility with functional polymorphisms Genetic susceptibility with functional polymorphisms Exposure to antigens leading to activation of macrophages Exposure to antigens leading to activation of macrophages Attainment of T-cell immunity against antigens mediated by antigen processing and presentation by macrophage Attainment of T-cell immunity against antigens mediated by antigen processing and presentation by macrophage Zissel
7
Sarcoidosis: Standard Rx Initial therapy: prednisone (often 2 yr) with variable initial dose, taper, & duration Initial therapy: prednisone (often 2 yr) with variable initial dose, taper, & duration Steroid-sparing Rx: Steroid-sparing Rx: Methotrexate Methotrexate Azathioprine Azathioprine Leflunomide Leflunomide Mycophenolate Mycophenolate Infliximab Infliximab Baughman; Chapelon-Abric.
8
Sarcoidosis vs. Crohn’s disease Similar pathology Unregulated T-cell activity Non-caseating granulomas
9
Sarcoidosis Rx: Role for LDN Regulate T-cell growth Regulate B-cell growth Decrease inflammation Decrease permeability Stabilize Toll-like receptors Decrease microglia activation Decrease cytokine release Shift from TH2 to TH1 Improve GI motility
10
Sarcoid Case 1 RashFatigueAdenopathyLiver/Spleen
11
Case 1 AH 73 y.o. AAF – supraglotic resection in 2001 d/t sarcoidosis. Sx weak voice, painful rash, fatigue, and parotitis Rash prevention by minocycline Hx MTX neuropathy Referred abnl CT LDN – prescribed
12
Progress 2015 February - LDN 1 mg/day March - less dyspnea, fatigue, able to stop minocycline w/o rash March – LDN increased 12 days to 4.5 mg May – Dec - less DOE, more energy July & Dec – CT’s showed reduction in the size of the splenic lesions and liver lesions
13
11/2011 12/2014 Before LDN
14
7/15 - 5 mo LDN 12/12 - 10 mo LDN
15
12/14 12/15 – 10 mo LDN
16
Sarcoid Case 2 PulmonaryFatigue
17
Case 2: PFB 64 y.o. AAF 26 yr pulmonary sarcoidosis 2 yr home O2 (24 hr/d; 2 L) Dyspnea (rest/activity) and dry cough 7/15 - Prednisone 20 mg Last used 16 yr ago 8/15 - LDN
18
Case 2: PFB 64 y.o. AAF 9/15 – 1 mo LDN No change 10/15 - 2 mo LDN Less fatigue Less dyspnea O 2 prn for vigorous activity Prednisone taper started
19
Sarcoid Case 3 Pulmonary
20
Case 3: PLB 63 y.o. WM Abnl CXR 17 yr ago – Bx: granulomas Hx osteopenia 2 yrs dyspnea with activity 8/20/15 - LDN 4.5 mg (titrated up from 1.5 over 2 wks)
21
Case 3: PLB 63 y.o. WM 1 mo after LDN – unchanged 2 mo after LDN – less short of breath 3 mo after LDN – asthma from allergens
22
Sarcoidosis Rx: Role for LDN Experience needed – enroll AA pts Pulmonary response w treadmill testing Pulmonary response w treadmill testing Anti-inflammatory markers Anti-inflammatory markers
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.